Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 6.75%207.7B | 6.66%801.81B | 6.82%194.57B | 8.88%751.78B | 8.72%185.81B | 7.73%194.27B | 9.72%189.56B | 9.43%182.15B | 6.43%690.46B | 8.81%170.91B |
| Cost of revenue | 6.16%154.36B | 6.27%597.72B | 6.19%145.41B | 8.47%562.46B | 9.80%139.04B | 7.27%144.66B | 8.61%141.83B | 8.29%136.93B | 5.34%518.52B | 6.24%126.63B |
| Gross profit | 8.51%53.34B | 7.80%204.09B | 8.71%49.16B | 10.10%189.32B | 5.61%46.76B | 9.10%49.61B | 13.15%47.73B | 13.01%45.22B | 9.87%171.95B | 16.90%44.28B |
| Operating expense | 7.39%41.06B | 7.60%159.59B | 8.26%38.24B | 10.28%148.32B | 7.34%38.98B | 7.27%37B | 13.11%37.02B | 14.10%35.32B | 9.83%134.49B | 16.14%36.31B |
| Staff costs | ---- | 7.46%58.94B | ---- | 8.98%54.84B | ---- | ---- | ---- | ---- | 6.82%50.33B | ---- |
| Depreciation and amortization | ---- | 15.12%17.28B | ---- | 25.02%15.01B | ---- | ---- | ---- | ---- | --12.01B | ---- |
| -Depreciation | ---- | 15.12%17.28B | ---- | 25.02%15.01B | ---- | ---- | ---- | ---- | --12.01B | ---- |
| Rent and land expenses | ---- | 6.23%33.34B | ---- | 6.06%31.38B | ---- | ---- | ---- | ---- | 7.30%29.59B | ---- |
| Other operating expenses | ---- | 6.27%50.03B | ---- | 10.60%47.08B | ---- | ---- | ---- | ---- | -10.88%42.57B | ---- |
| Operating profit | 12.42%12.28B | 8.54%44.5B | 10.30%10.92B | 9.46%41B | -2.28%7.78B | 14.84%12.61B | 13.29%10.71B | 9.30%9.9B | 9.99%37.46B | 20.50%7.97B |
| Net non-operating interest income (expenses) | -725.00%-50M | -114.77%-13M | -63.64%8M | 6.02%88M | -5.00%19M | 27.78%23M | 4.35%24M | 0.00%22M | -26.55%83M | -23.08%20M |
| Non-operating interest income | 7.14%30M | 25.83%151M | -3.45%28M | 0.84%120M | 7.41%29M | -3.13%31M | -13.89%31M | 20.83%29M | -2.46%119M | -10.00%27M |
| Non-operating interest expense | 300.00%80M | 412.50%164M | 185.71%20M | -11.11%32M | 42.86%10M | -42.86%8M | -46.15%7M | 250.00%7M | 300.00%36M | 75.00%7M |
| Net investment income | 28.57%9M | 0.00%3M | 16.67%7M | -1M | 33.33%4M | 1M | 0.00%3M | 0.00%6M | 0 | |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 198M | 0 | ||||||||
| Income from associates and other participating interests | 47.36%-259M | -1.57B | -492M | 0 | ||||||
| Special income (charges) | 11.11%-56M | 1.07%-463M | -65.79%-63M | -9.86%-468M | 87.35%-21M | -2,125.00%-89M | -31.69%-320M | -192.31%-38M | -647.37%-426M | -418.75%-166M |
| Less:Other special charges | -44.44%35M | 384.62%37M | 1,475.00%63M | 88.98%-13M | -1.53%-133M | 207.23%89M | -67.47%27M | -69.23%4M | -122.64%-118M | -723.81%-131M |
| Less:Write off | --21M | -11.43%426M | --0 | -11.58%481M | -48.15%154M | --0 | 83.13%293M | --34M | 394.55%544M | 2,600.00%297M |
| Other non-operating income (expenses) | -11.76%180M | 42.99%908M | 14.61%204M | 6.90%635M | -33.33%152M | 21.15%189M | -7.20%116M | 109.41%178M | 5.51%594M | 57.24%228M |
| Income before tax | 14.28%12.09B | 5.59%43.57B | 5.12%10.58B | 9.42%41.26B | -1.42%7.93B | 14.21%12.74B | 12.52%10.53B | 9.93%10.06B | 8.75%37.71B | 19.25%8.05B |
| Income tax | 26.03%4.15B | 5.64%12.82B | 3.95%3.29B | 1.06%12.13B | -41.40%1.59B | 14.25%4.01B | 14.99%3.38B | 10.78%3.16B | 10.96%12.01B | 42.68%2.71B |
| Net income | 8.97%7.94B | 5.58%30.75B | 5.65%7.29B | 13.32%29.13B | 18.84%6.35B | 14.20%8.73B | 11.36%7.15B | 9.56%6.9B | 7.76%25.7B | 10.11%5.34B |
| Net income continuous operations | 8.98%7.95B | 5.58%30.75B | 5.65%7.29B | 13.32%29.13B | 18.86%6.35B | 14.18%8.73B | 11.40%7.16B | 9.54%6.9B | 7.75%25.7B | 10.08%5.34B |
| Noncontrolling interests | 0 | 0 | 0 | 0 | 0 | |||||
| Net income attributable to the company | 8.97%7.94B | 5.58%30.75B | 5.65%7.29B | 13.32%29.13B | 18.84%6.35B | 14.20%8.73B | 11.36%7.15B | 9.56%6.9B | 7.76%25.7B | 10.11%5.34B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 8.97%7.94B | 5.58%30.75B | 5.65%7.29B | 13.32%29.13B | 18.84%6.35B | 14.20%8.73B | 11.36%7.15B | 9.56%6.9B | 7.76%25.7B | 10.11%5.34B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 8.97%67.92 | 5.56%262.91 | 5.61%62.33 | 13.30%249.07 | 18.81%54.25 | 14.17%74.62 | 11.36%61.18 | 9.56%59.02 | 7.75%219.83 | 10.10%45.66 |
| Diluted earnings per share | 8.97%67.92 | 5.56%262.91 | 5.63%62.33 | 13.31%249.07 | 18.81%54.25 | 14.19%74.62 | 11.34%61.1705 | 9.56%59.01 | 7.75%219.82 | 10.10%45.66 |
| Dividend per share | 0 | 14.04%130 | 0 | 14.00%114 | 14.00%57 | 0 | 14.00%57 | 0 | 40.85%100 | 38.89%50 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |